Genotype-phenotype correlation over time in Angelman syndrome: Researching 134 patients

被引:1
作者
Fujimoto, Masanori [1 ]
Nakamura, Yuji [1 ]
Hosoki, Kana [2 ,3 ]
Iwaki, Toshihiko [1 ]
Sato, Emi [1 ]
Ieda, Daisuke [1 ]
Hori, Ikumi [1 ,4 ]
Negishi, Yutaka [1 ]
Hattori, Ayako [1 ]
Shiraishi, Hideaki [2 ]
Saitoh, Shinji [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya 4678601, Japan
[2] Hokkaido Univ Hosp, Dept Pedi atr, Sapporo 0608648, Japan
[3] DigitalX, Astellas Pharm, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan
[4] Aichi Prefectural Welf Federat Agr Cooperat Kainan, Dept Pediat, Yatomi 4988502, Japan
来源
HUMAN GENETICS AND GENOMICS ADVANCES | 2024年 / 5卷 / 04期
关键词
GABA(A) RECEPTOR; UBE3A; EPILEPSY; DELETION; LIGASE; EXPRESSION; MUTATIONS; CHILDREN; FEATURES; GENE;
D O I
10.1016/j.xhgg.2024.100342
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by the loss of function of maternal UBE3A. The major cause of AS is a maternal deletion in 15q11.2-q13, and the minor causes are a UBE3A mutation, uniparental disomy (UPD), and imprinting defect (ID). Previous reports suggest that all patients with AS exhibit developmental delay, movement or balance disorders, behavioral characteristics, and speech impairment. In contrast, a substantial number of AS patients with a UBE3A mutation, UPD, or ID were reported not to show these consistent features and to show age-dependent changes in their features. In this study, we investigated 134 patients with AS, including 57 patients with a UBE3A mutation and 48 patients with UPD or ID. Although developmental delay was present in all patients, 20% of patients with AS caused by UPD or ID did not exhibit movement or balance disorders. Differences were also seen in hypopigmentation and seizures, depending on the causes. Moreover, patients with a UBE3A mutation, UPD, or ID tended to show fewer of the specific phenotypes depending on their age. In particular, in patients with UPD or ID, easily provoked laughter and hyperactivity tended to become more pronounced as they aged. Therefore, the clinical features of AS based on cause and age should be understood, and genetic testing should not be limited to patients with the typical clinical features of AS.
引用
收藏
页数:6
相关论文
共 40 条
  • [1] Andersen W H, 2001, Logoped Phoniatr Vocol, V26, P2, DOI 10.1080/140154301300109044
  • [2] The STARS Phase 2 Study A Randomized Controlled Trial of Gaboxadol in Angelman Syndrome
    Bird, Lynne M.
    Ochoa-Lubinoff, Cesar
    Tan, Wen-Hann
    Heimer, Gali
    Melmed, Raun D.
    Rakhit, Amit
    Visootsak, Jeannie
    During, Matthew J.
    Holcroft, Christina
    Burdine, Rebecca D.
    Kolevzon, Alexander
    Thibert, Ronald L.
    [J]. NEUROLOGY, 2021, 96 (07) : E1024 - E1035
  • [3] THE EEG IN EARLY DIAGNOSIS OF THE ANGELMAN (HAPPY PUPPET) SYNDROME
    BOYD, SG
    HARDEN, A
    PATTON, MA
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 1988, 147 (05) : 508 - 513
  • [4] Increased Body Mass in Infancy and Early Toddlerhood in Angelman Syndrome Patients with Uniparental Disomy and Imprinting Center Defects
    Brennan, Marie-Luise
    Adam, Margaret P.
    Seaver, Laurie H.
    Myers, Angela
    Schelley, Susan
    Zadeh, Neda
    Hudgins, Louanne
    Bernstein, Jonathan A.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (01) : 142 - 146
  • [5] Sleep disturbances in Angelman syndrome: a questionnaire study
    Bruni, O
    Ferri, R
    D'Agostino, G
    Miano, S
    Roccella, M
    Elia, M
    [J]. BRAIN & DEVELOPMENT, 2004, 26 (04) : 233 - 240
  • [6] Angelman syndrome - insights into a rare neurogenetic disorder
    Buiting, Karin
    Williams, Charles
    Horsthemke, Bernhard
    [J]. NATURE REVIEWS NEUROLOGY, 2016, 12 (10) : 584 - 593
  • [7] Clinical Characterization of Epilepsy in Children With Angelman Syndrome
    Cassater, Daiana
    Bustamante, Mariana
    Sach-Peltason, Lisa
    Rotenberg, Alexander
    Nespeca, Mark
    Tan, Wen-Hann
    Bird, Lynne M.
    Hipp, Joerg F.
    [J]. PEDIATRIC NEUROLOGY, 2021, 124 : 42 - 50
  • [8] Angelman syndrome: a review of the clinical and genetic aspects
    Clayton-Smith, J
    Laan, L
    [J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (02) : 87 - 95
  • [9] Dan B, 2003, NEUROPEDIATRICS, V34, P169
  • [10] DeLorey TM, 1998, J NEUROSCI, V18, P8505